Cytokinetics Inc vs Roundhill Russell 2000 0DTE Covered Call Strat ETF — how do they compare? Cytokinetics Inc trades at $62.02 (market cap $8.50B), while Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $25.96 (market cap $176.64M). The key difference: Cytokinetics Inc is far larger — about 48.1× Roundhill Russell 2000 0DTE Covered Call Strat ETF's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Roundhill Russell 2000 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and Roundhill Russell 2000 0DTE Covered Call Strat ETF for 53 Days on average.
| CYTK | RDTE | |
|---|---|---|
Market Cap | $8.50B | $176.64M |
Volume | 2,395,556 | 116,818 |
Sector | Health | Income / Options Overlay |
52-Week High | $87.26 | $33.66 |
52-Week Low | $54.76 | $25.96 |
Typical Hold Time | 19 Days | 53 Days |
Enterprise Value | $8.60B | — |
Signals from Pluang's Aura AI — not financial advice
CYTK trades at $61.12, down 0.37% on the day, with a bearish technical signal from moving averages but bullish momentum from oscillators. The company reported a net loss of -$784.96M on $88.04M revenue in 2025, with a negative net income margin of -1,321.12%. Recent news highlights clinical progress for aficamten in hypertrophic cardiomyopathy, including Phase 3 results and real-world study launches.
Despite heavy losses, strong analyst consensus (97.14% buy ratings) and a $112.50 price target reflect optimism for its heart failure pipeline. Key risks include sustained cash burn, competitive pressure from Bristol Myers Squibb's Camzyos, and the need for successful commercialization to justify its high P/S ratio of 112.42.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →